We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+32.24%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$145M
AUM Growth
+$19.4M
Cap. Flow
-$9.46M
Cap. Flow %
-6.51%
Top 10 Hldgs %
80.75%
Holding
47
New
9
Increased
8
Reduced
5
Closed
7

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.87M
2
AMZN icon
Amazon
AMZN
+$2.77M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.86M
4
MON
Monsanto Co
MON
+$1.58M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$824K

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$3.76M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.38M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.21M
4
INSY
Insys Therapeutics, Inc.
INSY
+$1.84M
5
CRM icon
Salesforce
CRM
+$1.59M

Sector Composition

Rank Sector Weight
1 Healthcare 60.02%
2 Consumer Discretionary 16.28%
3 Communication Services 12.76%
4 Financials 5.47%
5 Materials 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMS
26
DELISTED
Adamas Pharmaceuticals
ADMS
$495K 0.34%
30,140
– –
PNRA
27
DELISTED
Panera Bread Co
PNRA
$467K 0.32%
+2,400
New +$507K
PJT icon
28
PJT Partners
PJT
$4.26B
$409K 0.28%
15,000
+5,000
+50% +$125K
INSY
29
DELISTED
Insys Therapeutics, Inc.
INSY
$347K 0.24%
29,409
-121,229
-80% -$1.84M
PLSE icon
30
Pulse Biosciences
PLSE
$2.37B
$236K 0.16%
+37,454
New +$191K
ALDR
31
DELISTED
Alder Biopharmaceuticals
ALDR
$164K 0.11%
+5,000
New +$152K
SCOR icon
32
Comscore
SCOR
$113M
$153K 0.11%
+250
New +$142K
FOLD
33
DELISTED
Amicus Therapeutics
FOLD
$148K 0.1%
20,000
– –
TLGT
34
DELISTED
Teligent, Inc
TLGT
$105K 0.07%
1,382
-3,010
-69% -$239K
CCLD icon
35
CareCloud
CCLD
$103M
$60K 0.04%
63,771
– –
CPIX icon
36
Cumberland Pharmaceuticals
CPIX
$99.8M
$55K 0.04%
10,939
– –
VANI icon
37
Vivani Medical
VANI
$109M
$30K 0.02%
354
– –
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$19K 0.01%
5,025
– –
VXRT
39
DELISTED
Vaxart
VXRT
$17K 0.01%
783
– –
CXRX
40
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
$2K ﹤0.01%
+31
New +$389
AMZN icon
41
CALL
Amazon
AMZN
$2.44T
– –
-3,000
Closed -$10.3M
BMY icon
42
Bristol-Myers Squibb
BMY
$129B
– –
-30,000
Closed -$2.21M
CRM icon
43
Salesforce
CRM
$154B
– –
-20,000
Closed -$1.59M
JNJ icon
44
Johnson & Johnson
JNJ
$640B
– –
-6,000
Closed -$728K
SGNT
45
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-101,630
Closed -$1.52M
XNPT
46
DELISTED
XENOPORT, INC.
XNPT
– –
-50,000
Closed -$352K
NSPH
47
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-3,451
Closed -$6K
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, JW Asset Management held 47 positions worth $145M, up 15% from $126M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

JW Asset Management withdrew a net $9.46M in Q3 2016, closing 7 positions and reducing 5 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $2.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 54% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Alphabet (Google) Class A worth $6.03M.

  • JW Asset Management's largest Q3 2016 buy was Alphabet (Google) Class A: 150,000 shares worth $6.03M.
  • JW Asset Management added most to Amazon in Q3 2016, an estimated $2.77M increase.
  • JW Asset Management's biggest Q3 2016 reduction was Akorn Inc, cutting an estimated $3.76M.
  • JW Asset Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $2.21M.
  • JW Asset Management's ten largest holdings make up 81% of its $145M portfolio in Q3 2016.
  • JW Asset Management opened 9 new positions and closed 7 in Q3 2016.
  • JW Asset Management's portfolio value rose 15% quarter-over-quarter to $145M.

Based on JW Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.